Literature DB >> 16595054

Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkin's disease.

David Ledoux1, Vincent J Labombardi, Dennis Karter.   

Abstract

We report the case of a patient who developed bacteraemia and septic pulmonary emboli with Lactobacillus acidophilus after taking a probiotic containing this organism.

Entities:  

Mesh：

Year:  2006        PMID： 16595054     DOI： 10.1258/095646206776253507

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN： 0956-4624            Impact factor:   1.359


  20 in total

Review 1.  Future novel therapeutic agents for Clostridium difficile infection.

Authors:  Hoonmo L Koo; Kevin W Garey; Herbert L Dupont
Journal:  Expert Opin Investig Drugs       Date:  2010-07       Impact factor: 6.206

2.  Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.

Authors:  Alla Aroutcheva; Julie Auclair; Martin Frappier; Mathieu Millette; Karen Lolans; Danielle de Montigny; Serge Carrière; Stephen Sokalski; William E Trick; Robert A Weinstein
Journal:  Probiotics Antimicrob Proteins       Date:  2016-03       Impact factor: 4.609

Review 3.  Risk and safety of probiotics.

Authors:  Shira Doron; David R Snydman
Journal:  Clin Infect Dis       Date:  2015-05-15       Impact factor: 9.079

4.  Probiotic-associated aspiration pneumonia due to Lactobacillus rhamnosus.

Authors:  Christopher D Doern; Sean T Nguyen; Folashade Afolabi; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2014-06-04       Impact factor: 5.948

5.  Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host.

Authors:  Kerstin Gronbach; Ute Eberle; Martina Müller; Tobias A Olschläger; Ulrich Dobrindt; Frank Leithäuser; Jan Hendrik Niess; Gerd Döring; Jörg Reimann; Ingo B Autenrieth; Julia-Stefanie Frick
Journal:  Infect Immun       Date:  2010-04-26       Impact factor: 3.441

Review 6.  The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.

Authors:  Michel J van Vliet; Hermie J M Harmsen; Eveline S J M de Bont; Wim J E Tissing
Journal:  PLoS Pathog       Date:  2010-05-27       Impact factor: 6.823

7.  Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials.

Authors:  Eleni Pitsouni; Vangelis Alexiou; Vasilis Saridakis; George Peppas; Matthew E Falagas
Journal:  Eur J Clin Pharmacol       Date:  2009-03-27       Impact factor: 2.953

8.  Evaluation of Synergistic Interactions Between Cell-Free Supernatant of Lactobacillus Strains and Amikacin and Genetamicin Against Pseudomonas aeruginosa.

Authors:  Sargol Aminnezhad; Rouha Kasra Kermanshahi; Reza Ranjbar
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

Review 9.  Medical treatment of pouchitis: a guide for the clinician.

Authors:  Wendy Rabbenou; Shannon Chang
Journal:  Therap Adv Gastroenterol       Date:  2021-06-27       Impact factor: 4.409

10.  Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine.

Authors:  Rosalie Maltby; Mary P Leatham-Jensen; Terri Gibson; Paul S Cohen; Tyrrell Conway
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.